Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.Blood|July 18, 2022
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 studyMatthew M Heeney, Miguel R Abboud, Jessie Githanga, et al.The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Activated NK Cells with Pro-inflammatory Features are Associated with Atherogenesis in Perinatally HIV-Acquired AdolescentsMario Alles, Manuja Gunasena, Aaren Kettelhut, et al.Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.AIDS (London, England)|August 29, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trialAnne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, et al.The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.Journal of Tropical Pediatrics|September 17, 2016
Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor ResistanceRagna S Boerma, Cissy Kityo, T Sonia Boender, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.Pageof 16